Thomas Ebeling
Chair
Chair
Beauty x Medicine returns for its second season with special guest Nicolas Hieronimus, CEO of L’Oréal. His four decades in the beauty industry—all chez L’Oréal—have shown Nicolas that beauty isn’t just about meeting needs, but about “making dreams come true.”
Dr. Doris Day is a board-certified dermatologist, medical educator and author. In this episode of Beauty x Medicine, hosted by our CEO, Flemming Ørnskov, M.D., MPH, she explores how advances in dermatological science are transforming care for women navigating menopause.
The rise of rapid weight loss medications and their aesthetic impact is reshaping the field of aesthetic medicine, and with it, patient expectations. Dr. Andreas Nikolis is at the forefront of this transformation, as a board-certified plastic surgeon internationally recognized for his pioneering work in injectable aesthetics.
As a journalist, author and founder of the “Tweakments Guide,” Alice Hart-Davis is an influential mover in the aesthetics and beauty space. With more than 25 years of experience covering the aesthetics field for many of the top English-language publications, she has become a trusted expert on skincare and non-surgical cosmetic procedures. She even coined the term ‘’tweakments” to describe these procedures, which range from injectables and peels to energy devices and lasers. Alice has also published books on beauty for teenagers and adults.
Dr. Adam Friedman divides his time between academia and industry, serving as Professor and Chair of Dermatology at the George Washington University School of Medicine and Health Sciences and as Co-Chair of Galderma’s Global Sensitive Skincare Faculty (GSSF). This dual role brings a unique perspective, allowing him to drive ground-breaking research while developing innovative treatments that make a real impact on patients’ lives.
U.S.-based dermatologist Dr. Shawn Kwatra joins our CEO, Flemming Ørnskov, MD, MPH to discuss the trends, innovations and insights shaping the future of dermatology. Among those topics is chronic itch of unknown origin. Through pioneering research and contributions from experts like Dr. Kwatra, advancements in this area are in a key phase, offering patients tangible hope and support – like never before.
You are about to leave the Galderma global site. Are you sure you want to leave this page?